FMP

FMP

Enter

DAWN - Day One Biopharmaceu...

Discounted Cash Flow Model Levered of Day One Biopharmaceuticals, Inc.(DAWN), Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercia

photo-url-https://financialmodelingprep.com/image-stock/DAWN.png

Day One Biopharmaceuticals, Inc.

DAWN

NASDAQ

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

14.98 USD

-0.005 (-0.03338%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep